The YK-4-279 molecule was shown to target the chimeric protein EWS-FLI1 in Ewing sarcoma and impairs EWS-FLI1 activity and slow down tumor growth in mouse xenograft models [79,92]. Here, FLI1 is linked to neoplasm.